South Korea’s pharma tech startup Medility, the developer of the world’s No. 1 pill counting app Pilleye, has attracted pre-A investment from Kakao Ventures and BA Partners. The amount is confidential.
Medility’s Pilleye is an app that provides an Artificial Intelligence (AI)-based pill counting service. Since its launch in December 2020, it has received a good response, securing more than 150,000 pharmacists from 216 countries as customers in about a year. Medility helps pharmacists work more efficiently by improving drug dispensing and pharmacy operation systems. Pilleye is an app created based on the experience of founder Park Sang-eon, who has been operating a pharmacy for ten years.
Pilleye is increasing user base in the US & Canada
Pharmacists spend a certain amount of time each day counting and packing pills. The reality is that counting by hand is cumbersome and time-consuming, errors occur, and it is challenging to manage comprehensive data. But with Pilleye, dispensing prescriptions or managing drug inventory is much easier. Currently, it is possible to count up to 1000 tablets with an accuracy of 99.99% with one shot of a smartphone using Pilleye. Sorting using the app is more than 20 times faster than counting by hand, allowing pharmacists to focus on their work, free from the task of repeatedly counting pills. Another advantage is that all this data can be recorded and easily collected for management.
As of 2022, the number of monthly users for Pilleye in the US and Canada has exceeded 50,000. It is attracting attention in the industry for its high accuracy and speed compared to existing services. Medility plans to grow the pill counting app into a global pharmacy platform by helping the pharmacy operation more efficiently in pharmaceutical inspection and inventory management. In particular, as it becomes mandatory in the United States next year to record the entire process from drug production, distribution, and prescription, users’ needs for automated drug inventory management are expected to increase.
Park Sang-eon, CEO of Medility, said, “Based on rapid growth, we have monopolized the largest amount of pill image data in the industry. We want to become a global company that can contribute to global health through the digital transformation of pharmacies.” Kim Kim-won, managing director of Kakao Ventures, said, “This company, which started to solve the inconvenience of a former pharmacist, is highly likely to grow into a platform that helps pharmacists in general.”
Also Read,
- BiLabs: Revolutionary Technology in Cardiopulmonary Medicine
- Korean startup Constant’s app Refilled for hair loss problems attracts investment
- Korean startups in ‘non-face-to-face’ medical services see 161% growth in a month
- Korean startup Mediaiplus uses AI & big data analysis to ease clinical trial process for new drug development
by 
by 
